Biosimilar Newsletter Archive
-
10.05.23 -- Get The Most From Your Cell Culture
10/5/2023
10/05/23 Biosimilar Development Newsletter
-
10.05.23 -- Key Post-Pandemic Trends In Global FDA Observations For Drug Facilities
10/5/2023
10/05/23 Biosimilar Development Newsletter
-
10.02.23 -- Securing Your Consumables Supply Chain
10/2/2023
10/02/23 Biosimilar Development Newsletter
-
09.28.23 -- Abbott Broadens Access To Cutting-Edge Biosimilars In Key Emerging Markets
9/28/2023
09/28/23 Biosimilar Development Newsletter
-
09.26.23 -- Optimize Your Cell Line Preparation
9/26/2023
09/26/23 Biosimilar Development Newsletter
-
09.25.23 -- Improve Your Productivity With The Use Of Effective Modular Systems
9/25/2023
09/25/23 Biosimilar Development Newsletter
-
09.21.23 -- De-Risking Biosimilar Development With A Clinically Validated And Commercially Proven Disposable Autoinjector
9/21/2023
09/21/23 Biosimilar Development Newsletter
-
09.14.23 -- Biosimilars Forum Statement On CMS Announcement Of Drug Negotiation List
9/14/2023
09/14/23 Biosimilar Development Newsletter
-
09.13.23 -- Affinity Chromatography For mAbs, Mechanistic Modeling, And Polishing
9/13/2023
09/13/23 Biosimilar Development Newsletter
-
09.07.23 -- FDA Approves First Biosimilar To Treat MS
9/7/2023
09/07/23 Biosimilar Development Newsletter
This website uses cookies to ensure you get the best experience on our website. Learn more